The 2nd General Assembly Meeting took place virtually on 23. November 2023.
The project goals were sharpened, and the clinical study on focus groups and related proposals for ethics approvals are in preparation.
The overall legal and ethical framework document is finalised, with a special focus on AI topics.
Interviews with stakeholders as input for business and marketing strategies to support the commercialisation are foreseen.
A professional dashboard that includes the visualisation of the diagnosis and prognosis algorithms is under development.